Your browser doesn't support javascript.
loading
European Multicentre Tics in Children Studies (EMTICS): protocol for two cohort studies to assess risk factors for tic onset and exacerbation in children and adolescents.
Schrag, Anette; Martino, Davide; Apter, Alan; Ball, Juliane; Bartolini, Erika; Benaroya-Milshtein, Noa; Buttiglione, Maura; Cardona, Francesco; Creti, Roberta; Efstratiou, Androulla; Gariup, Maria; Georgitsi, Marianthi; Hedderly, Tammy; Heyman, Isobel; Margarit, Immaculada; Mir, Pablo; Moll, Natalie; Morer, Astrid; Müller, Norbert; Müller-Vahl, Kirsten; Münchau, Alexander; Orefici, Graziella; Plessen, Kerstin J; Porcelli, Cesare; Paschou, Peristera; Rizzo, Renata; Roessner, Veit; Schwarz, Markus J; Steinberg, Tamar; Tagwerker Gloor, Friederike; Tarnok, Zsanett; Walitza, Susanne; Dietrich, Andrea; Hoekstra, Pieter J.
Afiliação
  • Schrag A; Department of Clinical Neurosciences, UCL Institute of Neurology, University College London, London, UK.
  • Martino D; Department of Clinical Neurosciences, University of Calgary, Calgary, Canada.
  • Apter A; Child and Adolescent Psychiatry Department, Schneider Children's Medical Center of Israel, Affiliated to Sackler Faculty of Medicine, Tel Aviv University, Petah-Tikva, Israel.
  • Ball J; Clinic of Child and Adolescent Psychiatry and Psychotherapy, University of Zurich, Zurich, Switzerland.
  • Bartolini E; GSK, Siena, Italy.
  • Benaroya-Milshtein N; Child and Adolescent Psychiatry Department, Schneider Children's Medical Center of Israel, Affiliated to Sackler Faculty of Medicine, Tel Aviv University, Petah-Tikva, Israel.
  • Buttiglione M; Department of Biological Sciences and Human Oncology, Medical School, University of Bari "Aldo Moro", Bari, Italy.
  • Cardona F; Department of Human Neurosciences, University La Sapienza of Rome, Rome, Italy.
  • Creti R; Department of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy.
  • Efstratiou A; WHO Global Collaborating Centre for Reference and Research on Diphtheria and Streptococcal Infections, Reference Microbiology, Directorate National Infection Service, Public Health England, London, UK.
  • Gariup M; University of Barcelona, Barcelona, Spain.
  • Georgitsi M; Intensive Inpatient Unit, Copenhagen Psychiatric Center, Copenhagen, Denmark.
  • Hedderly T; Department of Molecular Biology and Genetics, Democritus University of Thrace, Alexandroupoli, Greece.
  • Heyman I; Department of Medicine, Aristotle University of Thessaloniki, Thessaloníki, Greece.
  • Margarit I; Evelina London Children's Hospital GSTT, Kings Health Partners AHSC, London, UK.
  • Mir P; Great Ormond Street Hospital for Children, UCL Institute of Child Health, London, UK.
  • Moll N; GSK, Siena, Italy.
  • Morer A; Unidad de Trastornos del Movimiento, Servicio de Neurología y Neurofisiología Clinica, Instituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocio/CSIC/Universidad de Sevilla, Seville, Spain.
  • Müller N; Institute of Laboratory Medicine, University Hospital, LMU Munich, Munich, Germany.
  • Müller-Vahl K; Department of Child and Adolescent Psychiatry and Psychology, Institute of Neurosciences, Hospital Clinic Universitari, Barcelona, Spain.
  • Münchau A; Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
  • Orefici G; Centro de Investigacion en Red de Salud Mental (CIBERSAM), Instituto Carlos III, Madrid, Spain.
  • Plessen KJ; Department of Psychiatry and Psychotherapy, University Hospital, LMU Munich, Munich, Germany.
  • Porcelli C; Marion von Tessin Memory-Zentrum gGmbH, Munich, Germany.
  • Paschou P; Clinic of Psychiatry, Social Psychiatry and Psychotherapy, Hannover Medical School, Hannover, Germany.
  • Rizzo R; Institute of Neurogenetics, University of Lübeck, Lübeck, Germany.
  • Roessner V; Department of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy.
  • Schwarz MJ; Child and Adolescent Mental Health Center, Mental Health Services, Capital Region of Denmark and University of Copenhagen, Copenhagen, Denmark.
  • Steinberg T; Service of Child and Adolescent Psychiatry, Department of Psychiatry, University Medical Center, University of Lausanne, Lausanne, Switzerland.
  • Tagwerker Gloor F; Azienda Sanitaria Locale di Bari, Mental Health Department, Child and Adolescent Neuropsychiatry Service of Bari Metropolitan Area, Bari, Italy.
  • Tarnok Z; Department of Biological Sciences, Purdue University, West Lafayette, USA.
  • Walitza S; Child Neuropsychiatry Section, Department of Clinical and Experimental Medicine, School of Medicine, Catania University, Catania, Italy.
  • Dietrich A; Department of Child and Adolescent Psychiatry, Faculty of Medicine, TU Dresden, Dresden, Germany.
  • Hoekstra PJ; Institute of Laboratory Medicine, University Hospital, LMU Munich, Munich, Germany.
Eur Child Adolesc Psychiatry ; 28(1): 91-109, 2019 Jan.
Article em En | MEDLINE | ID: mdl-29982875
ABSTRACT
Genetic predisposition, autoimmunity and environmental factors [e.g. pre- and perinatal difficulties, Group A Streptococcal (GAS) and other infections, stress-inducing events] might interact to create a neurobiological vulnerability to the development of tics and associated behaviours. However, the existing evidence for this relies primarily on small prospective or larger retrospective population-based studies, and is therefore still inconclusive. This article describes the design and methodology of the EMTICS study, a longitudinal observational European multicentre study involving 16 clinical centres, with the following

objectives:

(1) to investigate the association of environmental factors (GAS exposure and psychosocial stress, primarily) with the onset and course of tics and/or obsessive-compulsive symptoms through the prospective observation of at-risk individuals (ONSET cohort 260 children aged 3-10 years who are tic-free at study entry and have a first-degree relative with a chronic tic disorder) and affected individuals (COURSE cohort 715 youth aged 3-16 years with a tic disorder); (2) to characterise the immune response to microbial antigens and the host's immune response regulation in association with onset and exacerbations of tics; (3) to increase knowledge of the human gene pathways influencing the pathogenesis of tic disorders; and (4) to develop prediction models for the risk of onset and exacerbations of tic disorders. The EMTICS study is, to our knowledge, the largest prospective cohort assessment of the contribution of different genetic and environmental factors to the risk of developing tics in putatively predisposed individuals and to the risk of exacerbating tics in young individuals with chronic tic disorders.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transtornos de Tique Tipo de estudo: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Child / Child, preschool / Female / Humans / Male País como assunto: Europa Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transtornos de Tique Tipo de estudo: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Child / Child, preschool / Female / Humans / Male País como assunto: Europa Idioma: En Ano de publicação: 2019 Tipo de documento: Article